https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45063 p< 0.01) reduced the risk of dying, after adjusting for potential confounders. While, not counting on someone to trust (HR= 1.59; p< 0.03) and having a sense a lack of control over important decisions in life increased the mortality risk. Conclusions: Given that frailty and the SDH affect health using independent pathways, public health systems in Mexico could benefit from increasing the capacity of identifying frail and isolated older adults and providing a risk-stratified health care accordingly.]]> Wed 26 Oct 2022 11:43:11 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22891 Wed 11 Apr 2018 15:21:56 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49272 50 years old) at follow-up. Data were drawn from the first and second waves of the World Health Organization's Study on global AGEing and adult health. Self-report data captured sleep duration over two nights, and five cognitive tests (immediate and delayed verbal recall, forward and backward digit span, and verbal fluency) were used to measure various cognitive domains and create a composite z-score of cognitive performance. Linear regressions were performed to assess associations between sleep length changes and cognitive decline, controlling for relevant lifestyle and health factors. Increased sleep durations at follow-up among individuals who reported intermediate sleep durations (6-9 h/night) at baseline were significantly associated with greater rates of decline in overall cognitive function. Longer sleepers also trended toward greater rates of decline for attention/working memory and executive function. This study suggests that long sleep durations are a risk factor for certain types of impaired cognition among older adults living in a middle-income country. These findings are clinically important given the growing rates of dementia and aging populations globally.]]> Wed 10 May 2023 12:10:15 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35029 Tue 04 Jun 2019 14:19:50 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22820 Sat 24 Mar 2018 07:15:23 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:24781 Sat 24 Mar 2018 07:14:06 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41908 95% 1.11–1.48), and also the tertiles of disability (2nd tertile: OR = 1.45, CI_95% 1.23–1.70; 3rd tertile: OR = 2.19, CI_95% 1.81–2.66). The presence of multimorbidity was associated with an increase of 13% in average OOP health costs (β = 0.13, CI_95% 0.01–0.25), and 16% for the 3rd tertile of disability (β = 0.16, CI_95% 0.01–0.31). We did not find significant interaction effects of multimorbidity and disability. Conclusions: Multimorbidity and disability appear to be important determinants of OOP health expenditures. The economic implications for the households and the health system should be highlighted, particularly in low- and middle-income countries because of the rapid growth of their aging populations.]]> Mon 15 Aug 2022 15:11:20 AEST ]]>